amesergide
structure given in first source
Also Known As:
LY 237733; LY-237733; LY237733; Ergoline-8-carboxamide, N-cyclohexyl-6-methyl-1-(1-methylethyl)-, (8beta)-
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Weight Gain
11/01/1993
- " Amesergide, a serotonin (5-HT2) antagonist intended to treat depression, was administered orally to female CD rats (20/group) at doses of 0, 3, 10, or 30 mg/kg to evaluate effects on mating, fertility, litter size, live birth index (100 x total liveborn progeny/litter size), progeny survival, and weight gain of each litter. "
|
2. | Rhabdomyolysis
|
3. | Major Depressive Disorder (Major Depressive Disorders)
|
4. | Body Weight (Weight, Body)
|
5. | Alcoholism (Alcohol Abuse)
|
|
Related Drugs and Biologics